FrancophonIA/ELRC3.0 huggingface dataset:
English: Other information about Ristaben:
Croatian: Ostale informacije o lijeku Ristaben:
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Ristaben, including the appropriate precautions to be followed by healthcare professionals and patients.
Croatian: Na temelju tog plana, u sažetku opisa svojstava lijeka kao i u uputi o lijeku za Ristaben nalaze se sigurnosne informacije, uključujući odgovarajuće mjere opreza kojih se zdravstveni djelatnici i bolesnici trebaju pridržavati.
English: In the studies comparing Ristaben with other medicines, the effectiveness of adding Ristaben to metformin was similar to that of adding glipizide.
Croatian: U ispitivanjima koja su usporedila Ristaben s drugim lijekovima, djelotvornost dodavanja lijeka Ristaben metforminu bila je slična onoj kada se dodao glipizidu.
English: What is the risk associated with Ristaben?
Croatian: Koji su rizici povezani s lijekom Ristaben?
English: • three additional studies compared Ristaben with placebo when they were added to other diabetes medicines: glimepiride (another sulphonylurea), with or without metformin, in 441 patients; the combination of metformin and rosiglitazone (a PPAR-gamma agonist) in 278 patients; and a stable dose of insulin, with or without metformin, in 641 patients.
Croatian: • tri dodatna ispitivanja usporedila su Ristaben s placebom kada su dodani drugim lijekovima za dijabetes: glimepirid (druga sulfonilureja), s ili bez metformina, u 441 bolesnika; kombinacija metformina i rosiglitazona (agonista PPAR-gama) u 278 bolesnika; stabilna doza inzulina, s ili bez metformina u 641 bolesnika.
English: Hypoglycaemia has been reported in combination with a sulphonylurea in 4.7-13.8% of patients and with insulin in 9.6% of patients.
Croatian: Hipoglikemija je prijavljena u kombinaciji sa sulfonilurejom u 4,713,8% bolesnika i s inzulinom u 9,6% bolesnika.
English: Why has Ristaben been approved?
Croatian: Zašto je Ristaben odobren?
English: Together, these processes reduce blood glucose levels and help to control type 2 diabetes.
Croatian: Ovi procesi zajedno snižavaju razine glukoze u krvi i pomažu pri kontroli šećerne bolesti tipa 2.
English: By increasing levels of incretin hormones in the blood, sitagliptin stimulates the pancreas to produce more insulin when blood glucose levels are high.
Croatian: Povećavajući razine inkretinskih hormona u krvi, saksagliptin stimulira gušteraču kako bi gušterača proizvela više inzulina kada su razine glukoze u krvi visoke.
English: The CHMP decided that Ristaben's benefits are greater than its risks and recommended that it be given marketing authorisation.
Croatian: CHMP je odlučio da koristi od lijeka Ristaben nadmašuju s njim povezane rizike te je preporučio izdavanje odobrenja za stavljanje lijeka u promet.
English: Ristaben or placebo were used on their own in two studies involving 1,262 patients, as an add-on to metformin in one study involving 701 patients, and as an add-on to pioglitazone (a PPAR-gamma agonist) in one study involving 353 patients;
Croatian: Ristaben ili placebo uspoređeni su zasebno u dva ispitivanja koja su obuhvatila 1262 bolesnika, kao dodatak terapiji metforminom u jednom ispitivanju koje je obuhvatilo 701 bolesnika, te kao dodatak terapiji pioglitazonom (agonistom PPAR-gama) u jednom ispitivanju koje je obuhvatilo 353 bolesnika;
English: When taken on their own, Ristaben and metformin produced similar reductions in HbA1c levels, but the effectiveness of Ristaben seemed to be slightly lower than that of metformin.
Croatian: Kada su se uzimali kao monoterapije, Ristaben i metformin proizveli su ista smanjenja razina HbA1c, no čini se da je djelotvornost lijeka Ristaben nešto slabija od one metformina.
English: • two studies compared Ristaben with other diabetes medicines.
Croatian: • dva su ispitivanja usporedila Ristaben s drugim lijekom za dijabetes.
English: In patients taking Ristaben on its own, HbA1c levels fell from around 8.0% at the start of the studies by 0.48% after 18 weeks and 0.61% after 24 weeks.
Croatian: U bolesnika koji su uzimali Ristaben samostalno, koncentracije HbA1c spustile su se na otprilike 8,0% nakon početka ispitivanja za 0,48% nakon 18 tjedana te 0,61% nakon 24 tjedana.
English: Ristaben is a diabetes medicine that contains the active substance sitagliptin.
Croatian: Ristaben je lijek koji sadrži djelatnu tvar saksagliptin.
English: In contrast, they rose by 0.12% and 0.18%, respectively, in the patients taking placebo.
Croatian: Nasuprot tome, razine su se povisile za 0,12%, odnosno 0,18% u bolesnika koji su uzimali placebo.
English: One study compared Ristaben with glipizide (a sulphonylurea), when they were used as an add-on to metformin in 1,172 patients.
Croatian: Jedno je ispitivanje usporedilo Ristaben s glipizidom (sulfonilurejom), kada su se koristili kao dodatak terapiji metforminom u 1172 bolesnika.
English: Ristaben is used in patients with type 2 diabetes to improve the control of blood glucose (sugar) levels.
Croatian: Ristaben se koristi u bolesnika s dijabetesom tipa 2 za poboljšavanje kontrole razine glukoze (šećera) u krvi.
English: The other study compared Ristaben with metformin, used on their own, in 1,058 patients;
Croatian: Drugo je ispitivanje usporedilo Ristaben s metforminom, koji su korišteni kao monoterapije u 1058 bolesnika;
English: • in combination with insulin, with or without metformin, in patients who are not satisfactorily controlled on a stable dose of insulin.
Croatian: • u kombinaciji s inzulinom, s ili bez metformina, u bolesnika koji se ne mogu u zadovoljavajućoj mjeri kontrolirati stabilnom dozom inzulina.
English: What is Ristaben used for?
Croatian: Za što se Ristaben koristi?
English: What benefit has Ristaben shown during the studies?
Croatian: Koje su koristi lijeka Ristaben utvrđene u ispitivanjima?
English: Finally, they were reduced by 0.59% in patients adding Ristaben to insulin (with or without metformin), compared with a fall of 0.03% in those adding placebo.
Croatian: Naposljetku razine su smanjene za 0,59% u bolesnika koji su dodali Ristaben inzulinu (s ili bez metformina), u usporedbi s padom od 0,03% u onih koji su dodali placebo.
English: What is Ristaben?
Croatian: Što je Ristaben?
English: HbA1c levels were reduced by 1.03% after 18 weeks in patients adding Ristaben to metformin and rosiglitazone, compared with a fall of 0.31% in those adding placebo.
Croatian: Razine HbA1c snižene su za 1,03% nakon 18 tjedana u bolesnika dodavanjem lijeka Ristaben metforminu i rosiglitazonu, u usporedbi s padom od 0,31% u onih koji su dodali placebo.
English: How is Ristaben used?
Croatian: Kako se Ristaben koristi?
English: • in combination with both metformin, and a sulphonylurea or a PPAR-gamma agonist, in patients who are not satisfactorily controlled on the two medicines;
Croatian: • u kombinaciji s metforminom i sulfonilurejom ili agonistom PPAR-gama, u bolesnika koji se ne mogu u zadovoljavajućoj mjeri kontrolirati s ova dva lijeka;
English: In the additional studies, adding Ristaben to glimepiride (with or without metformin) led to a reduction in HbA1c levels of 0.45% after 24 weeks, compared with an increase of 0.28% in the patients adding placebo.
Croatian: U dodatnim ispitivanjima, dodavanje lijeka Ristaben glimepiridu (s ili bez metformina) rezultiralo je smanjivanjem u razinama HbA1c za 0,45% nakon 24 tjedna u usporedbi s povećanjem od 0,28% u bolesnika koji su dodali placebo.
English: • in combination with a sulphonylurea (another type of diabetes medicine) in patients who are not satisfactorily controlled with a sulphonylurea used on its own and in whom metformin is not suitable;
Croatian: • u kombinaciji sa sulfonilurejom (drugom vrstom lijeka za dijabetes) u bolesnika koji nisu u zadovoljavajućoj mjeri kontrolirani sulfonilurejom korištenim kao monoterapija i u kojih primjena metformina nije primjerena;
English: For the full list of all side effects and restrictions with Ristaben, see the package leaflet.
Croatian: Potpuni popis nuspojava i ograničenja zabilježenih pri primjeni lijeka Ristaben potražite u uputi o lijeku.
English: • in combination with metformin or a PPAR-gamma agonist (a type of diabetes medicine) such as a thiazolidinedione, in patients who are not satisfactorily controlled on metformin or the PPARgamma agonist used on its own;
Croatian: • u kombinaciji s metforminom ili agonistom PPAR-gama (tipom lijeka za dijabetes) poput tiazolidinediona, u bolesnika koji se ne mogu na zadovoljavajući način kontrolirati metforminom ili agonistom PPAR-gama kada se isti koriste kao monoterapija;
English: How does Ristaben work?
Croatian: Kako djeluje Ristaben?
English: • on its own, in patients who are not satisfactorily controlled on diet and exercise and in whom metformin (a diabetes medicine) is not suitable;
Croatian: • kao monoterapija, u bolesnika koji se ne mogu u zadovoljavajućoj mjeri kontrolirati prehranom i tjelovježbom, te u kojih primjena metformina (lijeka za dijabetes) nije primjerena;
English: In patients with moderately or severely reduced kidney function the dose of Ristaben should be reduced.
Croatian: Dozu lijeka Ristaben potrebno je smanjiti u bolesnika s umjereno ili ozbiljno smanjenom funkcijom bubrega.
English: When added to pioglitazone, Ristaben reduced HbA1c levels by 0.85% after 24 weeks, compared with a fall of 0.15% in the patients adding placebo.
Croatian: U slučaju kada se dodao pioglitazon, Ristaben je smanjio razine HbA1c za 0,85% nakon 24 tjedna, u usporedbi s padom od 0,15% u bolesnika koji su dodali placebo.
English: How has Ristaben been studied?
Croatian: Kako je Ristaben ispitivan?
English: HbA1c levels by 0.67% after 24 weeks, compared with a fall of 0.02% in the patients adding placebo.
Croatian: Dodavanje lijeka Ristaben metforminu snizilo je razine HbA1c za 0,67% nakon 24 tjedna, u usporedbi s padom od 0,02% u bolesnika kojima je dodan placebo.
English: MA (EU) Numbers (Invented) name
Croatian: Broj (EU) odobrenja (Zaštićeno) ime
English: Interaction with other medicinal products and other forms of interaction: No data available.
Croatian: Interakcije s drugim medicinskim proizvodima i drugi oblici interakcija: Nema dostupnih podataka.
English: Pharmacotherapeutic group: {not yet assigned} ATCvet code: {not yet assigned}
Croatian: Farmakoterapijska skupina: {nije još dodijeljena} ATCvet kod: {nije još dodijeljen}
English: For any further information about this veterinary medicinal product, please contact the local representative of the marketing authorisation holder.
Croatian: Za bilo koju informaciju o ovom veterinarsko-medicinskom proizvodu molimo kontaktirajte lokalnog predstavnika nositelja odobrenja za stavljanje u promet.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 29/03/2019
Croatian: Datum prvog odobrenja: 29/03/2019
English: Dispose of waste material in accordance with local requirements.
Croatian: Otpadni materijal zbrinuti u skladu s lokalnim propisima.
English: - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Croatian: - vrlo rijetke (manje od 1 životinje na 10.000 tretiranih životinja, uključujući izolirane slučajeve).
English: 2100 København Ø
Croatian: 2100 København
English: Then mix both the suspensions in the same syringe to produce one dose of the product (2 ml).
Croatian: Zatim pomiješajte obje suspenzije u istoj štrcaljki kako biste dobili jednu dozu proizvoda (2 ml).
English: Colourless and clear suspension.
Croatian: Bezbojna i prozirna suspenzija.
English: The excipients listed in section 6.1 of the SPC are either allowed substances for which table 1 of the annex to Commission Regulation (EU) No 37/2010 indicates that no MRLs are required or are considered as not falling within the scope of Regulation (EC) No 470/2009 when used as in this veterinary medicinal product.
Croatian: SPC-a su ili dozvoljene tvari za koje je u tablici 1. Priloga Uredbe Komisije (EU) br. 37/2010 navedeno da određivanje MRL-a nije nužno ili se smatra da nisu obuhvaćene Uredbom (EZ) br. 470/2009 kada se primjenjuju kao u ovom veterinarsko-medicinskom proizvodu.
English: Do not administer simultaneously with any other intraarticular veterinary medicinal product.
Croatian: Ne primjenjivati istodobno s drugim intraartikularnim veterinarsko-medicinskim proizvodom.
English: In an experimental model of osteoarthritis in horses these effects were reflected through parameters related to cartilage turnover.
Croatian: U pokusnom modelu osteoartritisa u konja ti su se učinci odrazili kroz parametre povezane s metabolizmom hrskavice.
English: The active substance being a principle of biological origin intended to produce passive immunity is not within the scope of Regulation (EC) No 470/2009.
Croatian: Djelatna je tvar biološkog podrijetla namijenjena izazivanju pasivne imunosti te se na nju ne primjenjuju odredbe Uredbe (EZ) br. 470/2009.
English: Use a needle with a diameter greater than or equal to 22G in order to prevent cell damage.
Croatian: Upotrijebite iglu promjera većeg ili jednakog 22G kako biste spriječili oštećenje stanica.
English: Dulbecco's Modified Eagle Medium Low Glucose
Croatian: Dulbecco modificirani Eagleov medij - niski sadržaj glukoze
English: Using appropriate gloves, remove the two vials (one vial of cells (1 ml) and one vial of EAP (1ml)) from the freezer/liquid nitrogen and thaw immediately at 25 °C - 37 °C, e.g. in a water bath, until the contents in each are completely thawed (approximately 5 minutes).
Croatian: Prikladnim rukavicama uzmite dvije bočice (jednu bočicu stanica (1 ml) i jednu bočicu EAP-a (1ml)) iz zamrzivača / tekućeg dušika i odmah ih odmrznite na temperaturi od 25°C do 37°C, npr. u vodenoj kupelji, do otapanja sadržaja obiju bočica (približno pet minuta).
English: No data available.
Croatian: Podatci nisu dostupni.
English: Overdose: No data available
Croatian: Predoziranje: Nema dostupnih podataka.
English: In order to avoid thrombosis in small vessels when administering intraarticular injections the correct placement of the needle is critical.
Croatian: Kako bi se izbjegla tromboza u malim krvnim žilama pri primjeni intraartikularnih injekcija, ključno je pravilno postaviti iglu.
English: The veterinary product must be administered intraarticularly by a veterinary surgeon taking special precautions to ensure sterility of the injection process.
Croatian: Veterinar mora veterinarski proizvod primijeniti intraartikularno uz posebne mjere opreza kako bi osigurao sterilnost postupka primjene injekcije.
English: Each pack (polycarbonate container) contains a single dose of the product: one vial of stem cell suspension and one vial of EAP suspension.
Croatian: Jedno pakiranje (spremnik od polikarbonata) sadrži jednu dozu proizvoda: jednu bočicu suspenzije matičnih stanica i jednu bočicu suspenzije EAP-a.
English: Mild increases in lameness and injection site reactions, such as mild to moderate increases in joint swelling and mild increases in temperature at the injection sites, occurred very commonly in the first week after use of the product.
Croatian: Blaga povećanja hromosti i reakcije na mjestu primjene injekcije, kao što su blaga do umjerena povećanja oticanja zglobova i blaga povišenja temperature na mjestu primjene injekcije, pojavljivala su se vrlo često tijekom prvog tjedna nakon primjene VMP-a.
English: After injection of the product the stem cells do not migrate or distribute from the treated joint and synovia to tissues surrounding the synovial space.
Croatian: Nakon primjene proizvoda injekcijom, matične stanice ne migriraju niti se distribuiraju iz liječenog zgloba i sinovije u tkivo koje okružuje sinovijsku ovojnicu.
English: The chondrogenic induction of the mesenchymal stem cells aims to activate chondroprotective mechanisms, such as the production of extracellular matrix.
Croatian: Hondrogena indukcija mezenhimskih matičnih stanica ima za cilj aktivirati hrondroprotektivne mehanizme, kao što je proizvodnja izvanstanične matrice.
English: Do not use this veterinary medicinal product after the expiry date which is stated on the labels.
Croatian: Ovaj se veterinarsko-medicinski proizvod ne smije upotrijebiti nakon isteka roka valjanosti navedenog na etiketi.
English: Dosage: A single intraarticular injection of 1 dose (2 ml) per animal.
Croatian: Doziranje: Jedna intraartikularna injekcija jedne doze (2 ml) po životinji.
English: The product needs to be administered immediately after thawing to prevent significant cell death.
Croatian: Proizvod treba primijeniti odmah nakon odmrzavanja kako bi se spriječila značajnija smrt stanica.
English: According to the benefit-risk assessment of the responsible veterinarian of the individual case a single dose systemic NSAID may be administered on the day of intraarticular injection.
Croatian: Prema procjeni nadležnog veterinara omjera rizika i koristi za pojedinačni slučaj, jedna doza sustavnog NSAID-a može se primijeniti na dan intraartikularne injekcije.
English: If any cell clusters are visible in either of the vials after thawing, gently shake the vial concerned until the suspension is clear and colourless (stem cell suspension) or clear and yellow (equine allogeneic plasma suspension: the diluent).
Croatian: Ako su u bilo kojoj bočici nakon otapanja vidljive stanične nakupine, nježno protresite bočicu dok suspenzija ne postane prozirna i bezbojna (suspenzija matičnih stanica) ili prozirna i žuta (suspenzija alogenične plazme konja: otapalo).
English: Use only accordingly to the benefit-risk assessment by the responsible veterinarian.
Croatian: Primijeniti samo nakon procjene odnosa koristi i rizika nadležnog veterinara.
English: Efficacy data are not available regarding treatment of other joints.
Croatian: Podatci o djelotvornosti liječenja drugih zglobova nisu dostupni.
English: ul.Franciszka Klimczaka 1, 02-797 Warszawa
Croatian: Boehringer Ingelheim Sp.z o.o. ul.Franciszka Klimczaka 1, 02-797 Warszawa
English: Shelf life after preparation of the suspension for injection according to directions: use immediately
Croatian: Rok valjanosti nakon pripreme suspenzije za injekciju u skladu s uputama: odmah upotrijebiti.
English: Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
Croatian: Ne primjenjivati u slučajevima preosjetljivosti na djelatnu tvar ili neku od pomoćnih tvari.
English: In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products.
Croatian: U nedostatku ispitivanja kompatibilnosti ovaj veterinarski proizvod ne smije se miješati s drugim veterinarsko-medicinskim proizvodima.
English: Remove the cap of the vial that thawed first and aspirate the suspension in a syringe, then remove the cap of the other (thawed) vial and aspirate the suspension in the same syringe.
Croatian: Uklonite poklopac s bočice koja se prva odmrznula i aspirirajte suspenziju u štrcaljku, a zatim uklonite poklopac s druge (odmrznute) bočice i aspirirajte suspenziju u istu štrcaljku.
English: The addition of the EAP to the stem cells after thawing and just before injection of the product increases the viability of the stem cells.
Croatian: Dodatak EAP-a matičnim stanicama nakon odmrzavanja te neposredno prije primjene injekcijom povećava održivost matičnih stanica.
English: MARKETING AUTHORISATION NUMBER(S) EU/2/18/228/001
Croatian: EU/2/18/228/001
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Arti-Cell Forte
Croatian: NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA
English: The handling of liquid nitrogen should take place in a well-ventilated area.
Croatian: Rukovanje tekućim dušikom potrebno je provesti u dobro prozračenom prostoru.
English: Cyclo-olefin co-polymer (COC) vial with a thermoplastic elastomer (TPE) stopper and a high-density polyethylene (HDPE) cap.
Croatian: Bočica cikloolefinskog kopolimera (COC) s čepom od termoplastičnog elastomera (TPE) i poklopcem od polietilena visoke gustoće (HDPE).
English: This product contains chondrogenic induced equine mesenchymal stem cells and equine allogeneic plasma (EAP).
Croatian: Ovaj proizvod sadrži hondrogeno inducirane, mezenhimske matične stanice konja i alogeničnu plazmu konja (EAP).
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Croatian: Učestalost nuspojava određena je u skladu sa sljedećim pravilima: - vrlo česte (više od 1 na 10 tretiranih životinja pokazuju nuspojavu(e)) - česte (više od 1 ali manje od 10 životinja na 100 tretiranih životinja) - manje česte (više od 1 ali manje od 10 životinja na 1.000 tretiranih životinja) - rijetke (više od 1 ali manje od 10 životinja na 10.000 tretiranih životinja) - vrlo rijetke (manje od 1 životinje na 10.000 tretiranih životinja, uključujući izolirane slučajeve).
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated)
Croatian: Učestalost nuspojava određena je u skladu sa sljedećim pravilima: - vrlo česte (više od 1 na 10 tretiranih životinja pokazuju nuspojavu(e)) - česte (više od 1 ali manje od 10 životinja na 100 tretiranih životinja) - manje česte (više od 1 ali manje od 10 životinja na 1.000 tretiranih životinja) - rijetke (više od 1 ali manje od 10 životinja na 10.000 tretiranih životinja)
English: The product must be manipulated and injected using sterile techniques and in a clean environment.
Croatian: Proizvodom treba rukovati te ga primijeniti s pomoću sterilnih tehnika u čistom okruženju.
English: Liquid nitrogen containers should be handled by properly trained personnel only.
Croatian: Sa spremnicima tekućeg dušika smije rukovati samo prikladno obučeno osoblje.
English: Active substance (1 ml):
Croatian: Pomoćne tvari (1 ml):
English: Shelf life after reconstitution according to directions: Use immediately.
Croatian: Rok valjanosti nakon rekonstitucije prema uputi: odmah upotrijebiti.
English: Excipients (1 ml):
Croatian: Djelatnu tvar (1 ml):
English: EXPIRY DATE EXP {month/year} Once reconstituted use immediately.
Croatian: EXP {mjesec/godina} Upotrijebiti odmah nakon rekonstitucije.
English: Single administration of 1 dose (equivalent to 2 ml) per animal
Croatian: Doziranje: Jedna primjena jedne doze (jednake 2 ml) po životinji
English: Preparation of the suspension for injection:
Croatian: Priprema suspenzije za injekciju:
English: In case of accidental self-injection this product can cause pain, local inflammatory reactions and swelling at the site of injection which may persist for several weeks and possibly cause fever, seek medical advice immediately and show the package leaflet or the label to the physician.
Croatian: U slučaju nehotičnog samoinjiciranja ovaj VMP može uzrokovati bol, lokalne upalne reakcije i oticanje na mjestu primjene injekcije koji mogu potrajati nekoliko tjedana te mogu uzrokovati vrućicu.
English: PACKAGE SIZE One vial (1 ml) of stem cells and one vial (1 ml) of equine allogeneic plasma.
Croatian: Jedna bočica (1 ml) matičnih stanica i jedna bočica (1 ml) alogenične plazme konja.
English: Equine allogeneic plasma suspension (diluent): clear yellow suspension.
Croatian: Suspenzija alogenične plazme konja (otapalo): prozirna, žuta suspenzija.
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Arti-Cell Forte suspension for injection for horses Chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells
Croatian: Arti-Cell Forte suspenzija za injekciju za konje Hondrogeno inducirane, alogenične mezenhimske matične stanice izvedene iz periferne krvi konja
English: 4.1 Target species
Croatian: KLINIČKI PODATCI 4.1 Ciljne vrste životinja